Alkem launches favipiravir under brand name Alfluenza
Favipiravir is approved by the DCGI restricted emergency use in India for the treatment of mild to moderate cases of COVID-19
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.